Tag: CPhI Japan
No posts to display
News
New research centre to improve tests and treatments for rare lung diseases
A £9.4 million collaborative research centre will accelerate improved tests, treatments and potentially cures for thousands of people living with rare respiratory diseases.
The LifeArc...
Mundipharma acquires all assets and rights related to REZZAYO® (rezafungin)
Mundipharma has acquired all assets and rights related to rezafungin globally from Cidara Therapeutics.
This provides Mundipharma with global ownership of rezafungin including ongoing development...
European Commission approves Pfizer’s EMBLAVEO for patients with multidrug-resistant infections
The European Commission (EC) has granted marketing authorization for Pfizer’s EMBLAVEO® (aztreonam-avibactam) for the treatment of adult patients with complicated intra-abdominal infections (cIAI), hospital-acquired...
